Regulatory Update — Week of July 29, 2024 Post author:PacConAdmin Post published:August 2, 2024 Post category:Uncategorized Post comments:0 Comments This week, the FDA published notice of user fee rates for fiscal year 2025. Source: Drug Industry Daily Tags: aaps Read more articles Previous PostQuick Notes: EU News Roundup — Aug. 2, 2024 Next PostBlood-Based Colorectal Cancer Screening Test Gets Thumbs Up From FDA You Might Also Like Sun Pharma Slapped With Warning Letter for Dadra Plant’s Multiple Violations July 8, 2024 BIO Raps “Questionable Data” in New Studies on IRA Impact on Biotech R&D August 15, 2024 PhRMA Files for Summary Judgment in IRA Drug Pricing Suit August 14, 2023 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
